Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.
about
Systematic review of health-related quality of life modelsAdvances in ITP--therapy and quality of life--a patient surveyFatigue in adult patients with primary immune thrombocytopenia.The development of romiplostim for patients with immune thrombocytopenia.ITP: a historical perspective.Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim.Cognitive symptoms are common in immune thrombocytopenia and associate with autonomic symptom burden.Prevalence of primary immune thrombocytopenia in Oklahoma.The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia.Immune thrombocytopenia -- what are the new treatment options?Health-related quality of life in adult patients with chronic immune thrombocytopenia in Serbia.Impact of self-administration of romiplostim by patients with chronic immune thrombocytopenia compared with administration by a healthcare provider.Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim.Fatigue in immune thrombocytopenia.Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopeniaHealth-related quality of life in children with chronic immune thrombocytopenia in China.An evaluation of overall effectiveness and treatment satisfaction with intravenous immunoglobulin among patients with immune thrombocytopenia.Fatigue as marker of thrombocytopenia in childhood idiopathic thrombocytopenic purpura.Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia
P2860
Q27011325-D25F193E-1FE5-4C04-B56F-223FC782626EQ28742871-B94DFADD-0E27-4F9A-8FD3-5668DC68EF5AQ33394156-163A96DB-46ED-4B21-8E7B-9E6D88D4A2D9Q33394636-39E3760E-1584-40A6-A8A1-F13CD722CF7AQ33394791-67CAC4E6-8A97-4BB2-AB43-19C0A1F717FFQ33397101-340B4FAD-CB5D-4A2E-AFDF-615CCFFD97A7Q33397931-D8B59954-5909-4DCC-8611-F3F52E14DDF5Q33401671-04718537-6377-48B7-8B2F-C72C6AE7FC67Q33407279-931470C1-CC2A-415D-9ECF-10AA151CB74BQ33407802-398C2D12-2205-49C8-BC24-A2C783BD3E03Q33411220-7BFCAEFB-5541-4E94-AF8F-8DE56963F238Q33416547-B0FC5337-79F9-4E45-A8AD-7F137E1DB1A8Q33419763-14A6D4C0-1858-4DB5-B464-2269A95F1C21Q33421555-4998B42B-BC45-48BA-9C1D-2E30AD4A727AQ33424537-F0F48A79-4422-4D04-B6EE-84D055774907Q33430741-C816BE5E-17E9-4DEE-B827-36C65BFBDA40Q33431970-F5503021-F2D2-489A-B86E-8B32F35AF86CQ50709052-4B7D68DF-0333-492B-AC3D-AF339BCC54DBQ59125749-695539FA-6FBC-4449-97E9-561E1E10B4DB
P2860
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Impact of chronic Immune Throm ...... with the patient perspective.
@ast
Impact of chronic Immune Throm ...... with the patient perspective.
@en
type
label
Impact of chronic Immune Throm ...... with the patient perspective.
@ast
Impact of chronic Immune Throm ...... with the patient perspective.
@en
prefLabel
Impact of chronic Immune Throm ...... with the patient perspective.
@ast
Impact of chronic Immune Throm ...... with the patient perspective.
@en
P2093
P2860
P921
P356
P1476
Impact of chronic Immune Throm ...... with the patient perspective.
@en
P2093
Claire Snyder
David Cella
Diane Kholos Wysocki
James N George
Janet L Nichol
Kimberly L Miller
Ralph Turner
Robert McMillan
P2860
P2888
P356
10.1186/1477-7525-6-13
P577
2008-02-08T00:00:00Z
P5875
P6179
1037526623